Arrowhead Pharmaceuticals, Inc. today announced interim results from a Phase 1/2a clinical study of ARO-CFB, the company's investigational RNA interference (RNAi) therapeutic targeting complement ...
A labor market boosted by immigration after the Covid pandemic faces a threat from President-elect Donald Trump's plan for ...
Forum Energy Technologies, Inc. (NYSE: FET) (“FET”) today announced that its Board of Directors has authorized a program for the repurchase of outstanding shares of FET’s common stock having an ...
Linkers Industries Limited (Nasdaq: LNKS) (the 'Company”), a manufacturer and a supplier of wire/cable harnesses with operation in Malaysia, today announced the closing of its initial public offering ...
All three patients from the non-randomized cohort of MOJAVE, a US randomized controlled multi-center Phase 1/2a clinical study, have been successfully treated with DSR, resulting in a dramatic ...
Muna Therapeutics (Muna), a biotechnology company focused on developing innovative therapeutics for neurodegenerative diseases, ...
(1)   The total number of outstanding shares of the Company mentioned in the relevant transparency notification amounts to 44,436,192, each share giving right to one (1) vote (being 44,436,192 voting ...
Last week, the Authority received legislative approval to issue Garvee bonds in the aggregate principal amounts of $156 million to be used to fund major infrastructure projects, including 1. St. Croix ...
Number of direct (non-aggregated) arguments of an ordered-set or hypothetical-set aggregate, counting a variadic array as one argument. If equal to pronargs, the aggregate must be variadic and the ...
Aggregate functions compute a single result from a set of input values. The built-in general-purpose aggregate functions are listed in Table 9.60 while statistical aggregates are in Table 9.61. The ...
LOS ANGELES--(BUSINESS WIRE)--Laekna, Inc. (2105.HK) (“Laekna”), a global biotech company focused on novel drug development for metabolic and cancer diseases, is pleased to announce a clinical ...